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Exposure of F9 cells to all-trans-retinoic acid over a period of 6 days resulted in 4-fold induction of cell 
surface N-acetylglucosaminide fi( l -+4)galactosyltransferase (GT) activity. The retinoic acid-induced GT 
activity was further enhanced by treatment of the cells with I-bromo cyclic AMP. The ability of retinoic 
acid alone, or retinoic acid in combination with 8-bromo cyclic AMP, to induce GT activity was inhibited 
by both actinomycin D and cycloheximide. These findings indicate that the induction of 
galactosyltransferase activity noted with differentiation of F9 cells involves de novo synthesis of new 
enzyme protein. 
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1. INTRODUCTION 
Differentiation 
bohydrates by catalyzing the transfer of sac- 
charides from sugar donors to the growing 
polysaccharide chain. On the cell surface, 
glycosyltransferases could participate in cellular 
interactions by binding specific carbohydrate 
substrates on adjacent cell surfaces [7]. In this 
manner, these cell surface enzymes have been 
postulated to modulate such biological processes 
as cell-cell adhesion [9] and cell migration [lo]. 
F9 embryonal carcinoma cells, the stem cells of 
teratocarcinomas, provide an in vitro system for 
the study of early biochemical events involved in 
embryonic differentiation and development [1,2]. 
Exposure of F9 cells to all-trans-retinoic acid in- 
duces differentiation to an endodermal cell type 
[3]. Cyclic AMP has been implicated as a 
modulator of cellular differentiation in a variety of 
cell types [4,5] and has been shown to promote the 
differentiation of F9 cells treated with retinoic acid 
[Ul. 
Cell surface and extracellular components are 
required for a number of cell-cell interactions. 
These components are usually glycoconjugates and 
their participation in mediating biological 
responses in a number of cell types has been 
established (review [7]). One such class of 
glycoconjugates are glycosyltransferases [8]. These 
enzymes synthesize a variety of complex car- 
Retinoic acid is known to alter cell surface 
glycoprotein metabolism [11,121 and in some cases 
this alteration appears to be a specific effect upon 
the addition of distal sugars [12]. Changes in the 
activity of glycosyltransferases have been de- 
scribed during viral transformation, altered proli- 
feration, and differentiation of cells [ 131. To deter- 
mine if changes in galactosyltransferase activity 
might correlate with changes related to the onset of 
embryonal carcinoma cell differentiation, we have 
investigated the effect of retinoic acid treatment of 
F9 cells on this enzymatic activity. 
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2. MATERIALS AND METHODS 
2.1. Materials 
Dulbecco-Vogt’s modified Eagle’s medium 
(DMEM) and fetal calf serum (FCS) were from 
Gibco. All-trans-retinoic acid was purchased from 
Eastman Kodak. Cycloheximide, 8-bromo cyclic 
AMP, UDP-galactose and N-acetylglucosamine 
were from Sigma; actinomycin D was from 
Calbiochem. UDP-D-[6-3H]galactose (16.3 Ci/ 
mmol) was purchased from Amersham. 
2.2. Growth of cells 
The F9 line of embryonal carcinoma cells was 
kindly provided by Dr Anton Jetten (NIEHS, 
Research Triangle Park, NC). Stock cultures of F9 
cells were maintained in DMEM with 10% FCS in 
a 5% CO2 humidified atmosphere. Cells were 
passaged every 3 days by mild trypsinization with 
0.05% trypsin containing 0.02% EDTA. Cells 
were counted with a Coulter counter (Coulter Elec- 
tronics, Hialeah, FL). 
2.3. Differentiation of F9 cells 
F9 cells were seeded at 1 x lo5 cells per 100 mm 
dish and allowed to attach and grow for 24 h. The 
growth medium then was changed to DMEM with 
10% FCS containing 0.1 ,uM all-trans-retinoic acid 
in the presence and absence of 1 mM 8-bromo 
cyclic AMP. All treatments with retinoic acid were 
carried out in the dark. 
To study the effect of actinomycin D and 
cycloheximide on the induction of galac- 
tosyltransferase activity, F9 cells were treated with 
retinoic acid for 48 h, followed by continued treat- 
ment with retinoic acid for an additional 24 h in 
the presence of cycloheximide (1 pg/ml medium) 
or actinomycin D (0.2/1g/ml medium). In ex- 
periments with 8.bromo cyclic AMP, Fs cells were 
exposed to retinoic acid for 6 days, followed by 
treatment with 1 mM 8-bromo cyclic AMP for an 
additional 24 h in the presence and absence of 
cycloheximide and actinomycin D as indicated. 
2.4. Gaiactosyltransferase assay 
F9 cells attached to the culture dish were washed 
3 times with phosphate-buffered saline and then 
twice with Hepes buffer (pH 7.2), containing Na+ 
and K+ (4.76 g/l Hepes, 7.5 g/l NaCI, 0.4 g/l 
KCI). Cells were detached from the dish by forcing 
this Hepes buffer over the cells. The detached cells 
were collected by centrifugation at 200 x g for 
10 min and the harvested cells washed once with 
the Na+- and K+-containing Hepes buffer. The cell 
pellet was resuspended in the Hepes buffer system 
to a final concentration of l-2 x 10’ cells/ml. The 
galactosyltransferase activity was linear with in- 
creasing cell number up to lo6 cells/ml. 
Galactosyltransferase activity was determined 
by measuring the transfer of [3H]galactose from 
UDP-[3H]galactose to N-acetylglucosamine to 
form ZV-acetyllactosamine. The reaction was in- 
itiated by the addition of 40 pl of cell suspension 
(-4 x 104 cells) to a reaction mixture containing 
125 pM UDP-[3H]galactose (16.3 Ci/mmol), 
6.3 mM MnC12, 26.6 mM Tris-HCl @H 7.4), and 
20 mM N-acetylglucosamine in a total volume of 
100 pl. After incubation at 37°C for 30 min, the 
reaction was terminated by the addition of an 
equal volume of ice-cold 20 mM EDTA. The ter- 
minated reaction mixture then was applied to a col- 
umn (4 x 0.6 cm) of Dowex AG-l-X8 equilibrated 
with water. After sample addition, the column was 
washed twice (0.2 ml/wash) with deionized water. 
The column then was eluted with 3 0.5-ml washes 
with deionized water to collect the N-acetyl[3H]lac- 
tosamine formed, and the 3 elution washes com- 
bined. The amount of N-acetyl[3H]lactosamine 
produced was determined by counting for radioac- 
tivity in the presence of Aquasol. To eliminate ar- 
tifacts due to variations in UDP-galactose 
hydrolase, controls were run in the absence of N- 
acetylglucosamine, and radioactivity determined in 
these samples (less than 5% of experimental 
values) were subtracted from the amount of 
radioactivity noted in the presence of N- 
acetylglucosamine. Enzyme activity is expressed as 
pmol N-acetyllactosamine formed/60 min per pg 
protein. 
2.5. Protein determination 
Protein was determined as in [14] with bovine 
serum albumin as the standard. 
3. RESULTS AND DISCUSSION 
To determine possible changes in cell surface 
galactosyltransferase activity which might occur 
during the differentiation of embryonal carcinoma 
cells, enzyme activity was measured with control F9 
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cells and with F9 cells treated with 0.1 pM retinoic 
acid for various time periods up to 6 days (fig.l). 
Little change in galactosyltransferase activity was 
observed during the first 24 h of retinoid treat- 
ment. After 2 and 3 days of retinoic acid treat- 
ment, however, there is a doubling in enzyme ac- 
tivity. This would correspond to the results of 
previous studies which have described a 2-3-day 
lag between initial treatment of F9 cells with 
retinoic acid and the appearance of cells with 
parietal endoderm-like properties [3,15,16]. The 
amount of galactosyltransferase activity was fur- 
ther increased in cells exposed to retinoic acid for 
4 and 6 days. This would agree with studies which 
indicate that there is continued conversion to the 
endoderm cell type with treatment of Fs cells with 
retinoic acid up to 10 days 1161. 
Cyclic AMP has been shown to promote retinoic 
acid-induced differentiation of F9 cells to en- 
doderm [6,15,16]. In agreement with these studies, 
in F9 cells treated for 3 and 6 days with retinoic 
acid and for an additional 24 h with retinoic acid 
in the presence and absence of 8-bromo cyclic 
AMP, cyclic AMP elicits a further 2-fold increase 
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Fig. 1. Effect of retinoic acid treatment of Fg cells on cell 
surface galactosyltransferase activity. Fs cells were 
grown in the presence or absence of 0.1 ,uM retinoic acid 
for the times indicated, and then galactosyltransferase 
activity was determined as described in section 2. cyclic AMP. Results are expressed as mean f SD. 
Fig.2. Effect of treatment of Fg cells with retinoic acid 
and with a combination of retinoic acid and 8-bromo 
cyclic AMP on cell surface galactosyltransferase 
activity. Fg cells were treated with 0.1 pM retinoic acid 
for 3 days, followed by an additional 24 h treatment 
with 0.1 pM retinoic acid with or without 1 PM 8-bromo 
in galactosyltransferase activity (fig.2). This 
change in enzyme activity is not observed when F9 
cells are treated with 8-bromo cyclic AMP alone 
(unpublished). Previously, it was reported that ex- 
posure of F9 cells to retinoic acid causes a pro- 
gressive increase in cyclic AMP-dependent protein 
kinase activity and provokes a rapid, preferential 
increase in the amount of the RII regulatory 
subunit of this kinase system associated with the 
plasma membrane [17]. On the basis of these find- 
ings, it was suggested that an increase in cyclic 
AMP-dependent protein kinase activity may be an 
early event of retinoic acid action to mediate other 
changes which take place during the differentiation 
process. The present results which show that cyclic 
AMP further enhances retinoid-induced changes in 
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galactosyltransferase activity are consistent with 
this suggestion. 
To establish if the induction of cell surface 
galactosyltransferase activity with retinoic acid 
was due either to stimulation of pre-existing en- 
zyme or increased biosynthesis of new enzyme pro- 
tein, studies were carried out with actinomycin D 
(an mRNA synthesis inhibitor) and cycloheximide 
(a protein synthesis inhibitor). In these studies, F9 
cells were treated with retinoic acid for 48 h with 
exposure to retinoic acid for an additional 24 h in 
the presence and absence of the inhibitors. The 
results presented in fig.3 show that both ac- 
tinomycin D and cycloheximide prevent the 
retinoic acid-mediated induction of galac- 
tosyltransferase activity. Similar results were ob- 
tained when actinomycin D and cycloheximide 
were added to F9 cells during treatment with 
retinoic acid in combination with cyclic AMP 
(fig.4). These findings indicate that the induction 
of galactosyltransferase activity in response to 
retinoic acid and cyclic AMP involves de novo syn- 
thesis of new enzyme protein. 
Increased amounts of cell surface galac- 
tosyltransferase during retinoid-induced differen- 
tiation of F9 cells may be required to add car- 
bohydrate moieties to existing or newly synthesized 
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Fig.3. Effect of actinomycin D and cycloheximide on the 
retinoic acid-mediated induction of galactosyltransfer- 
ase activity. F9 cells were treated with 0.1 PM retinoic 
acid for 2 days, followed by treatment with 0.1 pM 
retinoic acid for an additional 24 h in the presence and 
absence of cycloheximide (1 pg/ml growth medium) or 
actinomycin D (0.2 pg/ml growth medium). 
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Fig.4. Effect of actinomycin D and cycloheximide on the 
retinoic acid plus 8-bromo cyclic AMP-mediated 
induction of galactosyltransferase activity. F9 cells were 
treated with 0.1 PM retinoic acid for 6 days, followed by 
treatment with 0.1 pM plus 1 mM 8-bromo cyclic AMP 
for an additional 24 h in the presence and absence of 
cycloheximide (1 ,ug/ml growth medium) and 
actinomycin D (0.2 pg/ml growth medium) as indicated. 
glycoconjugates. Others have shown alterations in 
cell surface structure with differentiation [18]. A 
similar induction of galactosyltransferase activity 
has been described when human promyelocytic 
(HL60) cells were treated with retinoic acid [19]. 
Of interest also is a recent study which reports 
that a different glycosyltransferase, a fucosyltrans- 
ferase specific for the Fuccu( I-3)GlcNAc linkage, 
is decreased in F9 cells following treatment with 
retinoic acid and cyclic AMP [20]. This raises the 
possibility that reciprocal changes in cell surface 
glycosyltransferase activities (such as a decrease in 
fucosyltransferase accompanied by an increase in 
galactosyltransferase) could conceivably serve to 
modulate cell-cell interactions and thus to regulate 
growth and differentiation during embryonic 
development. 
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